U.S. Markets open in 5 hrs 8 mins

Trade Alert: The CEO, President & Director Of Cytosorbents Corporation (NASDAQ:CTSO), Phillip Chan, Has Just Spent US$59k Buying Shares

Simply Wall St

Whilst it may not be a huge deal, we thought it was good to see that the Cytosorbents Corporation (NASDAQ:CTSO) CEO, President & Director, Phillip Chan, recently bought US$59k worth of stock, for US$3.60 per share. However, we do note that it only increased their holding by 4.5%, and it wasn't a huge purchase by absolute value, either.

See our latest analysis for Cytosorbents

Cytosorbents Insider Transactions Over The Last Year

Notably, that recent purchase by Phillip Chan is the biggest insider purchase of Cytosorbents shares that we've seen in the last year. That implies that an insider found the current price of US$3.81 per share to be enticing. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. If someone buys shares at well below current prices, it's a good sign on balance, but keep in mind they may no longer see value. The good news for Cytosorbents share holders is that insiders were buying at near the current price.

In the last twelve months Cytosorbents insiders were buying shares, but not selling. The average buy price was around US$4.31. This is nice to see since it implies that insiders might see value around current prices. You can see the insider transactions (by individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!

NasdaqCM:CTSO Recent Insider Trading, December 11th 2019

Cytosorbents is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Insider Ownership of Cytosorbents

Many investors like to check how much of a company is owned by insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Insiders own 11% of Cytosorbents shares, worth about US$13m. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.

So What Do The Cytosorbents Insider Transactions Indicate?

The recent insider purchases are heartening. We also take confidence from the longer term picture of insider transactions. But on the other hand, the company made a loss last year, which makes us a little cautious. Insiders likely see value in Cytosorbents shares, given these transactions (along with notable insider ownership of the company). If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.